Dongqin Zhu

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Integrative fragmentomic and mutational signature profile of plasma cfDNA for early lung cancer detection.

Integrative fragmentomic and mutational signature profile of plasma cfDNA for early lung cancer detection.

Journal: NPJ precision oncology

Published: November 29, 2025

Noninvasive detection and prognostic stratification of biliary tract cancer using cell-free DNA fragmentomics: a model development and validation study.

Noninvasive detection and prognostic stratification of biliary tract cancer using cell-free DNA fragmentomics: a model development and validation study.

Journal: Molecular biomedicine

Published: November 11, 2025

Integrative cfDNA profiling from low-pass whole-genome sequencing enables tissue-of-origin prediction in cancer.

Integrative cfDNA profiling from low-pass whole-genome sequencing enables tissue-of-origin prediction in cancer.

Journal: Molecular biomedicine

Published: October 24, 2025

A machine learning framework combining cfDNA fragmentomics and serum biomarkers for early ovarian cancer detection.

A machine learning framework combining cfDNA fragmentomics and serum biomarkers for early ovarian cancer detection.

Journal: Cell communication and signaling : CCS

Published: October 24, 2025

Risk-stratified classification of pulmonary nodule malignancy via a machine learning model integrating imaging and cell-free DNA: a model development and validation study (DECIPHER-NODL).

Risk-stratified classification of pulmonary nodule malignancy via a machine learning model integrating imaging and cell-free DNA: a model development and validation study (DECIPHER-NODL).

Journal: The Lancet regional health. Western Pacific

Published: June 24, 2025

Noninvasive detection and differentiation of gastric malignancy using cell-free DNA biomarkers.

Noninvasive detection and differentiation of gastric malignancy using cell-free DNA biomarkers.

Journal: Journal of advanced research

Published: May 22, 2025

Development and Validation of a Cell-Free DNA Fragmentomics-Based Model for Early Detection of Pancreatic Cancer.

Development and Validation of a Cell-Free DNA Fragmentomics-Based Model for Early Detection of Pancreatic Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 01, 2025

Advanced ensemble staking model employing cfDNA fragmentation for early detection of esophageal and gastric cancer.

Advanced ensemble staking model employing cfDNA fragmentation for early detection of esophageal and gastric cancer.

Journal: Cancer letters

Published: April 25, 2025

A multi-center study for colorectal cancer early detection in high-risk disease patients using cell-free fragmentomics assay.

A multi-center study for colorectal cancer early detection in high-risk disease patients using cell-free fragmentomics assay.

Journal: Cancer cell international

Published: April 08, 2025

Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer.

Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer.

Journal: Cancer discovery

Published: February 26, 2025

Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics.

Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics.

Journal: Nature medicine

Published: August 23, 2024

Cell-free DNA Fragmentomics Assay to Discriminate the Malignancy of Breast Nodules and Evaluate Treatment Response.

Cell-free DNA Fragmentomics Assay to Discriminate the Malignancy of Breast Nodules and Evaluate Treatment Response.

Journal: Genomics, proteomics & bioinformatics

Published: April 08, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026